M R Wallace|D G Hooper - JoVE Visualize

Showing results (131-140 of 165) with videos related to

Pageof 17

Sort By:

Archives of Neurology|March 3, 1998

Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center GroupJ C Stout, R J Ellis, T L Jernigan, et al.

Human Genetics|August 1, 1986

Studies of a DNA marker (G8) genetically linked to Huntington disease in British familiesS Youngman, M Sarfarazi, O W Quarrell, et al.

Genomics|March 1, 1991

cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 geneR M Cawthon, L B Andersen, A M Buchberg, et al.

Genomics|December 1, 1991

cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene productD A Marchuk, A M Saulino, R Tavakkol, et al.

Annals of Neurology|December 10, 1997

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center GroupR J Ellis, K Hsia, S A Spector, et al.

Science (New York, N.Y.)|July 13, 1990

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patientsM R Wallace, D A Marchuk, L B Andersen, et al.

Science (New York, N.Y.)|September 21, 1984

DNA markers for nervous system diseasesJ F Gusella, R E Tanzi, M A Anderson, et al.

Sexually Transmitted Diseases|August 1, 1997

Neurocognitive impairment in human immunodeficiency virus infection is correlated with sexually transmitted disease historyM R Wallace, R K Heaton, J A McCutchan, et al.

The American Journal of Medicine|July 1, 1995

Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapyJ L Malone, M R Wallace, B B Hendrick, et al.

Journal of Medical Genetics|July 5, 2005

Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humansJ S Mogil, J Ritchie, S B Smith, et al.

Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:

Pageof 17

Archives of Neurology|March 3, 1998

Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center GroupJ C Stout, R J Ellis, T L Jernigan, et al.

Human Genetics|August 1, 1986

Studies of a DNA marker (G8) genetically linked to Huntington disease in British familiesS Youngman, M Sarfarazi, O W Quarrell, et al.

Genomics|March 1, 1991

cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 geneR M Cawthon, L B Andersen, A M Buchberg, et al.

Genomics|December 1, 1991

cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene productD A Marchuk, A M Saulino, R Tavakkol, et al.

Annals of Neurology|December 10, 1997

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center GroupR J Ellis, K Hsia, S A Spector, et al.

Science (New York, N.Y.)|July 13, 1990

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patientsM R Wallace, D A Marchuk, L B Andersen, et al.

Science (New York, N.Y.)|September 21, 1984

DNA markers for nervous system diseasesJ F Gusella, R E Tanzi, M A Anderson, et al.

Sexually Transmitted Diseases|August 1, 1997

Neurocognitive impairment in human immunodeficiency virus infection is correlated with sexually transmitted disease historyM R Wallace, R K Heaton, J A McCutchan, et al.

The American Journal of Medicine|July 1, 1995

Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapyJ L Malone, M R Wallace, B B Hendrick, et al.

Journal of Medical Genetics|July 5, 2005

Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humansJ S Mogil, J Ritchie, S B Smith, et al.

Pageof 17